Diabetes

Discover the hidden truths about diabetes that could revolutionize your understanding of this pervasive disease.

Alrestatin: A Glimpse into the World of Aldose Reductase Inhibitors

Martin Sparks

Alrestatin, an aldose reductase inhibitor, offers insights into potential diabetes complication treatments by targeting the enzyme responsible for sorbitol accumulation.

Azemiglitazone: A Promising Contender in Diabetes Treatment

Martin Sparks

Azemiglitazone is a promising new thiazolidinedione drug that enhances insulin sensitivity and offers potential benefits over existing diabetes treatments with fewer side effects.

Prusogliptin: A New Frontier in Diabetes Treatment

Martin Sparks

Prusogliptin, a novel DPP-4 inhibitor, shows promise in clinical trials for effectively managing type 2 diabetes with minimal side effects.